Sanctuary Advisors LLC Decreases Position in HCA Healthcare, Inc. (NYSE:HCA)

Sanctuary Advisors LLC reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 42.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,273 shares of the company's stock after selling 9,910 shares during the quarter. Sanctuary Advisors LLC's holdings in HCA Healthcare were worth $5,395,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in HCA. Nisa Investment Advisors LLC lifted its stake in HCA Healthcare by 8.8% in the second quarter. Nisa Investment Advisors LLC now owns 67,886 shares of the company's stock valued at $21,810,000 after buying an additional 5,464 shares during the last quarter. First Horizon Advisors Inc. grew its position in HCA Healthcare by 6.0% during the 2nd quarter. First Horizon Advisors Inc. now owns 1,496 shares of the company's stock worth $481,000 after purchasing an additional 85 shares during the last quarter. ZWJ Investment Counsel Inc. raised its holdings in shares of HCA Healthcare by 3.5% in the second quarter. ZWJ Investment Counsel Inc. now owns 1,082 shares of the company's stock valued at $348,000 after buying an additional 37 shares during the last quarter. Neo Ivy Capital Management acquired a new position in HCA Healthcare in the 2nd quarter valued at about $302,000. Finally, Commerzbank Aktiengesellschaft FI lifted its position in HCA Healthcare by 3.9% during the 2nd quarter. Commerzbank Aktiengesellschaft FI now owns 1,225 shares of the company's stock worth $394,000 after acquiring an additional 46 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

Insider Activity

In related news, SVP Phillip G. Billington sold 3,897 shares of the business's stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the company's stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now owns 6,843 shares of the company's stock, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.

Wall Street Analyst Weigh In

HCA has been the topic of a number of analyst reports. KeyCorp lowered their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating on the stock in a research report on Monday, October 28th. Truist Financial increased their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a "buy" rating in a report on Monday, August 19th. Wells Fargo & Company cut HCA Healthcare from an "equal weight" rating to an "underweight" rating and dropped their target price for the stock from $400.00 to $320.00 in a research report on Monday, November 25th. TD Cowen dropped their price objective on HCA Healthcare from $450.00 to $440.00 and set a "buy" rating on the stock in a report on Monday, October 28th. Finally, Morgan Stanley began coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an "equal weight" rating and a $427.00 target price on the stock. One analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and an average target price of $387.13.

HCA Healthcare Price Performance

NYSE:HCA traded down $4.33 during trading hours on Monday, reaching $309.60. 1,744,862 shares of the company traded hands, compared to its average volume of 1,206,436. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare, Inc. has a 1-year low of $263.22 and a 1-year high of $417.14. The firm's 50-day moving average is $355.34 and its 200-day moving average is $358.75. The stock has a market cap of $78.42 billion, a P/E ratio of 13.90, a P/E/G ratio of 1.21 and a beta of 1.63.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.85%. HCA Healthcare's dividend payout ratio is currently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.